Biomimetic Selenium‐Nanocomposites Alleviate MASH by Modulating Lipid and Iron Homeostasis
Advanced Healthcare Materials · 2025-07 · 14 (19)
DOI: 10.1002/adhm.202500467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.06.2025. Verfasst von Zhanpeng Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Minzu University Affiliated Enshi Clinical Medical School, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei Selenium a…. Hauptthemen laut MEDLINE: Iron, Selenium, Homeostasis, Lipid Metabolism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Metabolic dysfunction‐associated steatohepatitis (MASH) is a prevalent chronic liver disease characterized by steatosis, hepatitis, and fibrosis. Despite its global impact, a standardized clinical treatment protocol remains undeveloped. In this study, novel selenium nanoparticles (SeNPs) are synthesized using Lactobacillus coryniformis ES23 ( L. coryniformis ES23). It is found that SeNPs significantly mitigate liver steatosis, inflammation, and fibrosis induced by a choline‐deficient, L‐amino‐acid‐defined, high‐fat diet (CDAHFD). Mechanistically, SeNPs regulate fatty acid and triglyceride metabolism through the peroxisome proliferator‐activated receptor alpha (PPARα) pathway. Moreover, these results show that SeNPs maintain iron homeostasis by reducing the expression of heme oxygenase 1 (HMOX1) and transferrin receptor (TFRC), therefore decreasing iron accumulation and inhibiting ferroptosis in the mouse liver. Taken all, the findings in this study suggest that SeNPs can serve as a novel therapeutic approach for treating MASH via modulating lipid metabolism and ferrous ion homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Minzu University Affiliated Enshi Clinical Medical School, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei Selenium and Human Health Institute, the Central Hospital of Enshi Tujia and Mia…
- Hubei Provincial Key Lab of Selenium Resources and Bioapplications, Enshi, 445000, China.
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, 100193, China.
- School of Chemical Engineering, Ocean Technology and Life Science (CEOTLS), Dalian University of Technology, Panjin, 124221, China.
ORCID-Profile: Jianqiang Xu, Chuying Huang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Fundamental Research Funds for the Central Universities
- Liaoning Provincial Department of Human Resources and Social Security
- Health Commission of Hubei Province
Zitieren
APA
Zhang, Z., Fan, B., Zhou, C., Zhang, P., Liu, C., Xiang, Y., Xia, W., Sun, G., You, Y., Li, D., Xu, J., Huang, J., & Huang, C. (2025). Biomimetic Selenium‐Nanocomposites Alleviate MASH by Modulating Lipid and Iron Homeostasis. Advanced Healthcare Materials, 14(19). https://doi.org/10.1002/adhm.202500467
Vancouver
Zhang Z, Fan B, Zhou C, Zhang P, Liu C, Xiang Y, et al. Biomimetic Selenium‐Nanocomposites Alleviate MASH by Modulating Lipid and Iron Homeostasis. Advanced Healthcare Materials. 2025;14(19). doi:10.1002/adhm.202500467
BibTeX
@article{Zhang2025,
author = {Zhang, Zhanpeng and Fan, Bin and Zhou, Changyu and Zhang, Peipei and Liu, Chuanming and Xiang, Ying and Xia, Weinian and Sun, Guogen and You, Yufeng and Li, Dezhong and Xu, Jianqiang and Huang, Jiaqiang and Huang, Chuying},
title = {Biomimetic Selenium‐Nanocomposites Alleviate MASH by Modulating Lipid and Iron Homeostasis},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {19},
doi = {10.1002/adhm.202500467}
}
EUVIMED